NEW ORLEANS (MedPage Today) — Oral immunotherapy to induce desensitization to food allergies can be administered safely in the allergist’s office, according to a clinical report that stirred controversy over whether the approach should remain solely the jurisdiction of academic institutional research.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Wholesome Spice of Brooklyn, N.Y. spice company is recalling 25-pound boxes of commercial-grade crushed red pepper as the CDC and FDA investigate an outbreak of Salmonella Montevideo that infected consumers of Italian-style meats produced by a Rhode Island firm.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA initiated a class I, its most serious class, recall of the StatSpin Express 4 centrifuge due to potential injury caused by the device ejecting rotor shrapnel and blood during a malfunction.
No Comments »
Filed under: Pharmacy News
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
No Comments »
Filed under: Pharmacy News
Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced [...]
No Comments »
Filed under: Pharmacy News
Data presented today suggest that 20 percent liquid formulation, Immune Globulin Subcutaneous (Human) (SCIg), or IgPro20 effectively protects patients with primary immunodeficiencies (PI) against infection. The 20 percent formulation, the highest Ig concentration currently available, was also shown to sustain serum IgG levels without causing unexpected rates of adverse events. The data were presented at [...]
No Comments »
Filed under: Pharmacy News
Cannabis Science Inc., a pharmaceutical cannabis company in the US, is pleased to announce that it now has the results of its survey of more than 1,300 individuals with PTSD, including a large cohort of veterans. The survey was conducted by Cannabis Science Advisory Board member Dr. Mitch Earleywine PhD. of the State University of [...]
No Comments »
Filed under: Pharmacy News
Celsion Corporation today announced that it will initiate a Randomized Phase II Study of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Radiofrequency Ablation (RFA) for Colorectal Liver Metastases (CRLM). Dr. Steven K. Libutti, Professor and Vice Chairman, Department of Surgery and Director of the Montefiore-Einstein Center for Cancer Care and Albert Einstein College of Medicine in New [...]
No Comments »
Filed under: Pharmacy News
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced today the dosing of the first patient in a Phase I study of the investigational neuroprotective agent, QPI-1007.
No Comments »
Filed under: Pharmacy News
OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the [...]
No Comments »
Filed under: Pharmacy News
